We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
WFMPM
251
Woodley Farra Manion Portfolio Management
Indiana
$36.5M -$48.4K -858 -0.1%
OI
252
Oakbrook Investments
Illinois
$36.3M -$1.09M -19,314 -3%
ZIG
253
Zurich Insurance Group
Switzerland
$35.5M +$8.92M +158,149 +35%
IG
254
ING Group
Netherlands
$35.4M -$2.3M -40,765 -6%
SW
255
SVB Wealth
Massachusetts
$35M -$1.6M -28,422 -4%
Bank of Nova Scotia
256
Bank of Nova Scotia
Ontario, Canada
$35M -$24.1M -427,528 -41%
NLI
257
Nippon Life Insurance
Japan
$34.4M
HCMT
258
Highland Capital Management (Tennessee)
Tennessee
$34M -$1.91M -33,770 -5%
CBT
259
Capital Bank & Trust
California
$33.5M +$11.7M +207,924 +56%
BMO
260
Beck Mack & Oliver
New York
$33.5M -$543K -9,618 -2%
ELC
261
Edgar Lomax Company
Virginia
$33.5M +$228K +4,035 +0.7%
GC
262
Guggenheim Capital
Illinois
$33.3M -$62.6M -1,109,775 -66%
MSL
263
Mackay Shields LLC
New York
$33.2M -$596K -10,558 -2%
Truist Financial
264
Truist Financial
North Carolina
$33.1M -$831K -14,734 -3%
SDIC
265
South Dakota Investment Council
South Dakota
$32.9M -$114K -2,022 -0.4%
PL
266
Perpetual Ltd
Australia
$32.9M -$6.83M -121,149 -18%
PWLP
267
Prio Wealth Limited Partnership
Massachusetts
$32.6M -$563K -9,971 -2%
SAM
268
Shell Asset Management
Netherlands
$32.2M -$5.13M -90,965 -14%
HTC
269
Haverford Trust Company
Pennsylvania
$32M -$481K -8,530 -2%
DLA
270
Douglas Lane & Associates
New York
$31.6M +$202K +3,582 +0.7%
KAM
271
Krensavage Asset Management
New York
$31.3M -$2.18M -38,593 -7%
NMIMC
272
Northwestern Mutual Investment Management Company
Wisconsin
$31.3M +$1.44M +25,584 +5%
CT
273
Cambridge Trust
Massachusetts
$31.2M -$385K -6,828 -1%
PR
274
Payden & Rygel
California
$31.1M
Connor, Clark & Lunn Investment Management (CC&L)
275
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$30.9M -$26.5M -470,578 -47%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.